% | $
Quotes you view appear here for quick access.

Mylan N.V. Message Board

  • livermore1929 livermore1929 Dec 16, 2011 5:44 PM Flag

    New drug approval announced after close today

    Mylan Gets FDA Final Approval For Generic Toprol-XL (MYL)
    1 hours 51 minutes ago - Financial News Network Online - News Corner via Comtex

    Mylan (NASDAQ:MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Metoprolol Succinate Extended-release Tablets USP, 25 mg, 50 mg, 100 mg, and 200 mg.

    This product is the generic version of AstraZeneca's (NYSE:AZN) Toprol-XL Tablets, which are indicated for the treatment of hypertension.

    Mylan (NASDAQ:MYL) has potential upside of 23.1% based on a current price of $20.8 and an average consensus analyst price target of $25.6.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
41.655-0.405(-0.96%)11:56 AMEDT